- Home
- NERV vs MTR Comparison
NERV vs MTR Comparison
Compare NERV & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- MTR
- Stock Information
- Founded
- NERV 2007
- MTR 1979
- Country
- NERV United States
- MTR United States
- Employees
- NERV N/A
- MTR N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- MTR Oil & Gas Production
- Sector
- NERV Health Care
- MTR Energy
- Exchange
- NERV Nasdaq
- MTR Nasdaq
- Market Cap
- NERV 12.4M
- MTR 11.7M
- IPO Year
- NERV 2014
- MTR N/A
- Fundamental
- Price
- NERV $1.59
- MTR $5.23
- Analyst Decision
- NERV Hold
- MTR
- Analyst Count
- NERV 1
- MTR 0
- Target Price
- NERV $5.00
- MTR N/A
- AVG Volume (30 Days)
- NERV 7.7K
- MTR 5.2K
- Earning Date
- NERV 05-20-2025
- MTR 01-01-0001
- Dividend Yield
- NERV N/A
- MTR 3.55%
- EPS Growth
- NERV N/A
- MTR N/A
- EPS
- NERV 0.19
- MTR 0.25
- Revenue
- NERV N/A
- MTR $731,355.00
- Revenue This Year
- NERV N/A
- MTR N/A
- Revenue Next Year
- NERV N/A
- MTR N/A
- P/E Ratio
- NERV $8.42
- MTR $20.85
- Revenue Growth
- NERV N/A
- MTR N/A
- 52 Week Low
- NERV $1.15
- MTR $4.84
- 52 Week High
- NERV $3.69
- MTR $9.98
- Technical
- Relative Strength Index (RSI)
- NERV 46.58
- MTR 44.45
- Support Level
- NERV $1.65
- MTR $5.18
- Resistance Level
- NERV $1.75
- MTR $5.32
- Average True Range (ATR)
- NERV 0.08
- MTR 0.10
- MACD
- NERV -0.00
- MTR 0.04
- Stochastic Oscillator
- NERV 31.03
- MTR 48.10
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.